Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should ...

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

Industry leaders have said the Union Budget 2026 has laid the groundwork for a major shift in India's pharmaceutical sector, with the Biopharma SHAKTI initiative expected to reduce reliance on ...

The volatile biotech industry has braved the global trade war relatively well in the first half of 2025. While a pause in the tariff war between the United States and China has lent some stability, ...

Accomplished industry leader Robert J. Dempsey brings extensive commercialization and ophthalmic expertise Gary S. Jacob, Ph.D., will transition to Chief Development Officer and continue to serve on ...

Unless amended, the mechanism could result in an 'Innovation Fund' without innovative therapies, industry warns ...

India's pharma industry shifts to value-driven approaches, focusing on complex generics, innovation, and expanding medical device exports.

The so-called “mother of all deals” lowers import tariffs on European pharma exports from 11% to zero and also eliminates ...

In the run-up to the Union Budget 2026 presentation, healthcare leaders are urging a push toward technology-driven medical ...

Nandita Vijayasimha, Bengaluru Tuesday, January 27, 2026, 08:00 Hrs [IST] ...

The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S.

India Inc can draw inspiration from the domestic pharma industry, which transformed itself in the aftermath of the TRIPS ...